InformasjonDet eneste virkelig effektive tiltak ved Buergers sykdom er røykestopp. Hvis du ikke slutter å røyke, vil sykdommen alltid forverres selv om du får annen behandling.
Buergers sykdom
Buergers sykdom er en sykdom der det dannes blodpropper i små og mellomstore arterier og vener i armer og ben. Sigarettrøyking er en vesentlig årsaksfaktor.
Sist oppdatert:
12. sep. 2023
Vil du vite mer
Dette dokumentet er basert på det profesjonelle dokumentet Buergers sykdom . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Piazza G, Creager MA. Thromboangiitis obliterans. Circulation 2010; 121:1858. Circulation
- Nassiri N. Thromboangiitis obliterans (Buerger disease). Medscape, last updated Dec 19, 2016. emedicine.medscape.com
- Elbadawi A, Sedhom R, Megaly M, et al. Estimate and Temporal Trends of Buerger Disease Hospitalizations in the United States. Am J Cardiol 2022; 169: 158. pmid:35168750 PubMed
- Arkkila PET. Trombangiitis obliterans (Buerger's disease). Orphanet J Rare Dis 2006; 1: 14. doi: 10.1186/1750-1172-1-14 DOI
- Fakour F, Fazeli B. Visceral bed involvement in thromboangiitis obliterans: a systematic review. Vasc Health Risk Manag. 2019;15:317-353. Published 2019 Aug 15. doi:10.2147/VHRM.S182450 DOI
- Olin JW. Current concepts: Trombangiitis obliterans (Buergers disease). Review article. N Engl J Med 2000; 343: 864-9. PubMed
- Espinoza LR. Buerger's disease: thromboangiitis obliterans 100 years after the initial description. Am J Med Sci. 2009 Apr. 337(4):285-6.
- Vijayakumar A, Tiwari R, Kumar Prabhuswamy V . Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.. Int J Inflam 2013. pmid:24102033 PubMed
- Stranden E, Slagsvold C-E. Arterielle sår i underekstremiteten. Tidsskr Nor Lægeforen 2005; 125: 895-8. Tidsskrift for Den norske legeforening
- Agarwal P, Agrawal PK, Sharma D, Baghel KD. Intravenous infusion for the treatment of diabetic and ischaemic non-healing pedal ulcers. J Eur Acad Dermatol Venereol. 2005; 19: 158-62. pmid:15752282 PubMed
- Bozkurt AK, Köksal C, Demirbas MY, et al. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease. Int Angiol 2006; 25: 162-8. pmid:16763533 PubMed
- Paraskevas KI, Trigka AA, Samara M. Successful intravenous regional sympathetic blockade (Bier's Block) with guanethidine and lidocaine in a patient with advanced Buerger's Disease (thromboangiitis obliterans)--a case report. Angiology 2005; 56: 493-6. PubMed
- Modaghegh MS, Hafezi S. Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease). Vasc Endovascular Surg. 2018;52(2):124-130. doi:10.1177/1538574417744085 DOI
- Le Joncour A, Soudet S, Dupont A, et al. Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients.. J Am Heart Assoc 2018; 7: e010677. pmid:30571594 PubMed